Lucknow’s CDRI finds success in clinical trials of a new drug to be used for treating COVID
In a remarkable breakthrough, Lucknow's Central Drug Research Institute (CDRI) announced the success of clinical trials for Umifenovir, an antiviral ...
In a remarkable breakthrough, Lucknow's Central Drug Research Institute (CDRI) announced the success of clinical trials for Umifenovir, an antiviral ...
Augmenting the range of medical resources available for the treatment of COVID patients, Roche India introduced the first set of ...
In a moment of relief, the first stock of DRDO-crafted anti-COVID drug, 2-DG (2-deoxy-D-glucose) was flagged off earlier this week, ...